Atas, D. Et Al. 2021. The prevalence of metabolic syndrome is increased in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.53, no.7 , 1427-1434.

Atas, D., Atas, H., İzgi, T. N., Velioglu, A., Arikan, H., Oner, F., ... Direskeneli, H.(2021). The prevalence of metabolic syndrome is increased in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.53, no.7, 1427-1434.

Atas, DİLEK Et Al. "The prevalence of metabolic syndrome is increased in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis," INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.53, no.7, 1427-1434, 2021

Atas, DİLEK B. Et Al. "The prevalence of metabolic syndrome is increased in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis." INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.53, no.7, pp.1427-1434, 2021

Atas, D. Et Al. (2021) . "The prevalence of metabolic syndrome is increased in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis." INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.53, no.7, pp.1427-1434.

@article{article, author={DİLEK BARUTÇU ATAŞ Et Al. }, title={The prevalence of metabolic syndrome is increased in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis}, journal={INTERNATIONAL UROLOGY AND NEPHROLOGY}, year=2021, pages={1427-1434} }